Pluristem Therapeutics


Pluristem Therapeutics Stock Quote
$9.58 $0.27 2.9%
Price as of November 27, 2020, 6:00 p.m. EST View Interactive PSTI Charts

Pluristem Therapeutic is a bio-therapeutics Company dedicated to the commercialization of non-personalized cell therapy products for the treatment of several severe degenerative ischemic and autoimmune disorders.

Interactive Chart

News & Analysis: Pluristem Therapeutics


Market Moves

This Week in Biotech: Part 2

A look at the biggest stories this week in biotech and what they mean for investors.